<DOC>
	<DOCNO>NCT01273454</DOCNO>
	<brief_summary>This study aim collect clinical information examine usefulness safety ORal Osmotic System Hydromorphone Korean cancer patient . The decision treat patient drug per physician discretion dos determine base upon approved labeling recommendation physician discretion .</brief_summary>
	<brief_title>An Observational Study Investigate Clinical Usefulness OROS Hydromorphone Korean Cancer Patients</brief_title>
	<detailed_description>The primary purpose observational study collect clinical data cancer pain control use OROS ( ORal Osmotic Active System ) hydromorphone investigate clinical usefulness OROS hydromorphone Korean cancer patient . Information effectiveness cancer pain control adverse event report patient use OROS Hydromorphone report . In addition , clinical usefulness OROS hydromorphone evaluate assess sleep disturbance due pain , breakthrough pain , end-of-dose failure study drug administration examine patient 's satisfaction study drug investigator 's global assessment . This multi-center , open-label , prospective , exploratory , observational study approximately 770 patient . Efficacy endpoint analyze examine difference treatment . Since observational study condition routine practice , OROS Hydromorphone dosage adjust discretion investigator , base patient response . It recommend dosage conservative first adjust appropriately consider adverse event analgesic effect patient .</detailed_description>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>Patients need OROS hydromorphone relieve cancer pain Patients serious gastrointestinal disease may interfere oral analgesic effect , dysphagia , vomit , absence periastalsis , intestinal obstruction , and/or severe strangulation , case absorption passage orallyadministered medication may unduly influenced</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Open-label</keyword>
	<keyword>Non-interventional</keyword>
	<keyword>OROS hydromorphone</keyword>
	<keyword>Korean cancer patient</keyword>
</DOC>